Medicare Enrolled
Dr. Soorena Khojasteh, MD
Pain Medicine · Wynnewood, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khojasteh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khojasteh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khojasteh
Dr. Soorena Khojasteh is a pain medicine specialist in Wynnewood, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Khojasteh performed 1,147 Medicare services across 941 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khojasteh received a total of $5,268 from 46 pharmaceutical and/or device companies across 176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khojasteh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 30% volume in PA
$5,268 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,147
Medicare services
Top 30% in PA for pain medicine
941
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~67 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $93 | $235 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
231 | $123 | $362 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
108 | $101 | $394 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
92 | $68 | $155 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
70 | $42 | $200 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
52 | $1 | $12 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
37 | $84 | $550 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
34 | $65 | $472 |
| Minimally invasive spine decompression, lower spine A minimally invasive procedure to remove bone from the lower spine to relieve pressure on nerve tissue, guided by imaging and accessed through the skin. |
29 | $767 | $3,260 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
29 | $77 | $432 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
27 | $45 | $155 |
| Spinal neurostimulator electrode insertion A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system. |
24 | $259 | $2,950 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
20 | $75 | $540 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
19 | $48 | $140 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
12 | $158 | $935 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,268
Total received (2018-2024)
Avg $753/year across 7 years
Top 25% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
176
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,486 (85.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$782 (14.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,052
2023
$593
2022
$1,247
2021
$572
2020
$474
2019
$1,246
2018
$84
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$267
Vertos Medical, Inc.
$219
Collegium Pharmaceutical, Inc.
$139
Abbott Laboratories
$110
SCILEX PHARMACEUTICALS INC.
$90
Averitas Pharma Inc.
$74
Takeda Pharmaceuticals U.S.A., Inc.
$47
Stryker Corporation
$40
Medtronic, Inc.
$25
Fidia Pharma USA Inc.
$24
Nevro Corp.
$18
Top 3 companies account for 59.4% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$1,889
Abbott Laboratories
$531
Boston Scientific Corporation
$464
Vertos Medical, Inc.
$462
Collegium Pharmaceutical, Inc.
$211
Electronic Waveform Lab, Inc.
$176
UCB, Inc.
$114
SCILEX PHARMACEUTICALS INC.
$114
Medtronic, Inc.
$104
Amgen Inc.
$99
Averitas Pharma Inc.
$90
Scilex Pharmaceuticals Inc.
$84
BOSTON SCIENTIFIC CORPORATION
$70
Biohaven Pharmaceutical Holding Company Ltd.
$58
Teva Pharmaceuticals USA, Inc.
$53
Biohaven Pharmaceuticals, Inc.
$48
Takeda Pharmaceuticals U.S.A., Inc.
$47
GRT US Holding, Inc.
$42
Avanir Pharmaceuticals, Inc.
$41
Stryker Corporation
$40
Lilly USA, LLC
$35
Alexion Pharmaceuticals, Inc.
$32
Promius Pharma LLC
$31
Merz Pharmaceuticals, LLC
$30
ACADIA Pharmaceuticals Inc
$28
Fidia Pharma USA Inc.
$24
Bausch Health US, LLC
$24
Acorda Therapeutics, Inc
$23
Curonix LLC
$23
SI-BONE, Inc.
$23
Virtus Pharmaceuticals LLC
$21
Celgene Corporation
$20
MDD US Operations, LLC
$18
SK Life Science, Inc.
$18
PROTEGA PHARMACEUTIALS LLC
$17
Ultragenyx Pharmaceutical Inc.
$17
ABBVIE INC.
$17
Smith+Nephew, Inc.
$17
Edwards Lifesciences Corporation
$17
Biogen, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Terumo Medical Corporation
$14
UPSHER-SMITH LABORATORIES LLC
$14
AbbVie Inc.
$13
Novartis Pharmaceuticals Corporation
$12
Arbor Pharmaceuticals, Inc.
$12
Top 3 companies account for 54.7% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AJOVY · APOKYN · AUSTEDO · Aimovig · BOTOX · Belbuca · Briviact · ClearSight System · Cryvista · EMGALITY · EPIDIOLEX · ETERNA · GENERAL PAIN MANAGEMENT · GILENYA · General - Pain Management · HYMOVIS · HYQVIA · Horizant · INBRIJA · INCEPTIV · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Infinity DBS Pulse Generators · LACTULOSE · MIGRANAL · MILD DEVICE KIT · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuromodulation Dspsbls and Accs · OCTRODE · Omnia · PICO 7 Single Use Negative Pressure Wound Therapy · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · QULIPTA · QUTENZA · Quattrode Leads SCS Leads · Qutenza · Roxybond · SOLIRIS · SPECTRA WAVEWRITER · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Soliris · Superion · TOSYMRA · VADO · Vimpat · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (85%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
86
Per 100K population
10.0
County median income
$111,521
Nearest hospital
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khojasteh is a clinical cardiology specialist, with above-average Medicare volume (top 30% in PA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khojasteh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Khojasteh performed 363 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khojasteh receive payments from pharmaceutical companies?
Yes. Dr. Khojasteh received a total of $5,268 from 46 companies across 176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khojasteh's costs compare to other pain medicines in Wynnewood?
Dr. Khojasteh's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khojasteh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Wynnewood
Browse pain medicines in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in PA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in PA
Which PA pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology